Summary Fluorescence in situ hybridisation (FISH) has been used increasingly for gene mapping and ordering probes on interphase and metaphase preparations. The association of consistent chromosomal aberrations with certain malignancies allows the possibility of using interphase cytogenetics as a diagnostic tool. In small round cell tumours of children accurate diagnosis may be difficult using existing methods Small round cell tumours in children and adolescents, particularly neuroblastoma, Ewing's sarcoma, peripheral neuroectodermal tumour (PNET), and rhabdomyosarcoma, frequently present diagnostic difficulty, especially in their most undifferentiated forms (Donner, 1991) . Their histology may be virtually identical, and electron microscopy, immunocytochemistry, cytogenetic and molecular studies may be necessary to define tumour type reliably. Correct diagnosis is of paramount importance to clinician and patient alike for therapeutic decisions and prognosis.
Summary Fluorescence in situ hybridisation (FISH) has been used increasingly for gene mapping and ordering probes on interphase and metaphase preparations. The association of consistent chromosomal aberrations with certain malignancies allows the possibility of using interphase cytogenetics as a diagnostic tool. In small round cell tumours of children accurate diagnosis may be difficult using existing methods. We have therefore evaluated the diagnostic potential of this technique when applied to the characteristic t (11;22) found in Ewing's sarcoma and peripheral neuroectodermal tumour (ES and PNET).
Interphase nuclei were prepared from normal human foreskin fibroblasts (HFF), two Ewing's sarcoma cell lines and several fresh tumour biopsies. DNA probes each side of the breakpoint at 22ql2 were labelled with biotin and digoxygenin, hybridised to chromosomes in interphase and detected in different colours. Measurements between pairs of signals arising from each copy of chromosome 22 were taken and statistical analysis performed.
There was a highly significant difference (P<0.0001) between the two populations of measurements obtained (from nuclei with and without the t (11;22) Small round cell tumours in children and adolescents, particularly neuroblastoma, Ewing's sarcoma, peripheral neuroectodermal tumour (PNET), and rhabdomyosarcoma, frequently present diagnostic difficulty, especially in their most undifferentiated forms (Donner, 1991) . Their histology may be virtually identical, and electron microscopy, immunocytochemistry, cytogenetic and molecular studies may be necessary to define tumour type reliably. Correct diagnosis is of paramount importance to clinician and patient alike for therapeutic decisions and prognosis.
Under these circumstances the finding of a chromosomal abnormality in the tumour cells is invaluable. Consistent and specific chromosome translocations have been found to be associated with a number of human malignancies including leukaemias and lymphoma (Dewald et al., 1985) , and more recently with solid tumours (Fletcher et al., 1991) . These include the t(11;22) (q24;ql2) in the majority of cases of Ewing's sarcoma (Aurias et al., 1983; Turc-Carel et al., 1983) and many PNETs (Donner, 1991; Whang Peng et al., 1984) , the t(2;13)(q35;ql4) in alveolar rhabdomyosarcoma (Donner, 1991) , and del(lp) in neuroblastoma (Donner, 1991; Weith et al., 1989) . These characteristic chromosome aberrations can be used reliably to distinguish the different tumours, and in some cases can also give an indication of prognosis (Christiansen & Lampert, 1988) . However, accurate karyotyping of metaphase preparations from solid tumours is difficult due to poor chromosome spreading and banding, and condensed or fuzzy appearance of chromosomes. In addition, areas of necrosis in the biopsy and a low mitotic index in the viable material often result in few metaphases being obtained.
By utilising the technique of FISH on non-mitotic (interphase) preparations these technical difficulties can be avoided. Furthermore, by using direct preparations of fresh material, culturing of tumour cells may be unnecessary, or limited to 48 hours, avoiding possible selection of a highly proliferative sub-population of tumour cells which may not be representative. Longer term culture also tends to result in (Figure 1 ).
DNA probes
The two DNA probes used were the closest to the breakpoint at 22q12 that we had available at the time. CosS262 is a 35 kb cosmid derived from an endclone (D22S262) of a YAC located immediately above the breakpoint (Shipley et al., submitted) . CosLIF is a 45 kb cosmid for the Leukaemia Inhibitory Factor, isolated using a 300 bp probe derived from the LIF exon (Gough et al., 1988; Budarf et al., 1989; Selleri et al., 1991) . (Figure 2 ).
The probes were labelled by nick-translation with biotin-11-dATP (BRL Bio-nick kit) or else with digoxygenin-11-dUTP (Boehringer, Mannheim, Germany) according to the instructions of the supplier. The probes were purified through a Sephadex G50 column and precipitated with salmon sperm DNA and E. coli tRNA.
In situ hybridisation (Williams et al., 1991) Hybridisation and detection were performed according to our modification of the technique described by Pinkel et al (1986) . For one colour FISH 40 ng of each biotinylated probe was mixed with 10 gg of unlabelled CotI DNA (Gibco BRL). For two colour experiments 80 ng of LIF cosmid labelled with biotin and 60 ng of cosS262 labelled with digoxygenin were mixed with 10 ig of Cotl DNA. We have found these quantities to be optimal in producing signals of equal intensity with minimal background fluorescence. Cotl DNA has been found to be more efficient at reducing signal from repetitive sequences than total human DNA (Landegent et al., 1987) . The probe/ competitor mixture was dried in a vacuum centrifuge and resuspended in 11 jd hybridisation mix (10% dextran sulphate, 2 x SSC, 50% formamide, 1% Tween 20, pH 7), denatured at 75°C, chilled on ice and preannealed at 37°C for up to 3 h. Hybridisation was then performed overnight at 37°C under a sealed coverslip. U U U detected with FITC (green)). To ensure that measurements were between different probes the experiments were repeated in two colours. CosS262 (labelled with digoxygenin) was detected with FITC and cosLIF (labelled with biotin) detected with texas-red. Six slide preparations (from two separate cultures) were scanned for each of HFF and RD-ES. HFF and RD-ES nuclei were photographed and the relative distances between signals analysed by taking measurements (in millimetres) directly from slides projected onto a screen (Trask et al., 1989) .
In normal (control) cells the expected result is two pairs of signals indicating the positions of the two adjacent probes on each copy of chromosome 22. In two colour experiments each pair consists of one red and one green signal (cosLIF and cosS262 respectively).
Cells carrying the t(l 1;22)(q24;q12) diagnostic of Ewing's sarcoma should show one pair of signals (on the normal chromosome 22) and two separate signals i.e. cosS262 remaining on chromosome 22 above the breakpoint and cosLIF translocated to chromosome 11 (Figures 3 and 4) .
Statistical methods Ratios of the distances recorded for the two pairs of signals in each nucleus (two colour experiments only) were calculated for the HFF and RD-ES nuclei. The larger distance was always used as a numerator for the ratio since there was no obvious ordering between the pairs of measurements; all values were therefore greater than or equal to one. In order to assess whether the HFF ratios differed from the RD-ES ratios, a two sample rank test called the Mann-Whitney test was used (Altman, 1991) . This test assumes that the ratios observed in the HFF and RD-ES nuclei are random samples taken from two populations characterised by similar variation but different medians.
In order to determine how many pairs of measurements should be carried out in practice in the diagnosis of tumours with the t (I 1;22) we have used a computer-intensive method known as 'bootstrap' (Efron & Tibshirani, 1986) . This method allowed us to simulate the populations of HFF and RD-ES ratios from which the original observations were sampled. From these two populations new random samples of different sizes could then be generated.
We have considered sample sizes of 10, 20, 30 and We have simulated the population from which the original sample was taken and then generated from this new population new (random) samples of different sizes. For each sample size this has been repeated 100 times. We have then compared the medians found in the samples of different sizes. (Table I ). With a sample size of 30 measurements meeting the study criteria we have a 95% confidence interval for the median ratio in nuclei without the t(ll;22) of (1.19,1.59) and a 95% confidence interval for the median ratio in nuclei with t(ll;22) of (3.63,6.23). The two intervals are well apart. A sample size of 40 only slightly improves the discrimination between the two groups.
Application of the test to tumour samples Four tumour samples and one more cell line (EW11, from G. Lenoir, (Turc-Carel et al., 1983) ) from which nuclei had already been prepared underwent FISH exactly as described above. All of these had been karyotyped previously and diagnoses made. One slide was processed for each sample: the number of evaluable nuclei was satisfactory on all five slides, so no part of the experiment had to be repeated. Assessment of results by fluorescent microscopy was carried out blind by one observer (CT). The first 30 nuclei on each slide which met the criteria for the study were included. For each of these an estimate (by eye) of the ratio of the two distances between pairs of signals was recorded. The estimates were limited to 1, 1.5, 2, 3, 4, 5, 6 and >6. In addition these same 30 nuclei were photographed, measurements were taken and ratios were calculated as (Lawrence et al., 1990) , so a meaningful estimate of the distance between cosLIF and cosS262 cannot be made. We have since produced another cosmid which, from our ordering work, maps between cosS262 and the breakpoint (Shipley et al., submitted 1992) . This is currently being studied to see whether if it were used instead of cosS262 the resulting diagnostic test would require even fewer nuclei to be examined. However, some normal nuclei are unavoidably present in the tumour samples, so sufficient nuclei must always be viewed to minimise the risk of false negative results. If the median ratio for 30 nuclei in a particular specimen falls between the two 95% confidence intervals given for the two populations, then the number of nuclei included should be increased until a meaningful result is reached.
Inevitably this technique will not make a diagnosis of Ewing's sarcoma or PNET in those cases which do not carry (Donner et al., 1991; Gorman et al., 1991) . However, with the application of increasingly sophisticated molecular technology, the proportion of tumours believed to be without the translocation is reducing and it may now be hypothesised that apparently t(l1;22) negative cases in reality have complex translocations or insertions involving 22ql2. This situation can be compared to that of Philadelphia negative CML, in which bcr-abl fusion can be detected by molecular methods in cytogenetically Ph negative samples (Tkachuk et al., 1990; Shtalrid et al., 1988) . If this proves to be the case it is advantageous at this stage to use probes which are outside the critical area around the breakpoint on chromosome 22, since otherwise possible variants (perhaps currently regarded as t(l 1;22) negative) could also be missed. Thus it is possible that this test will pick up a higher proportion of tumours with a translocation involving chromosome 22. In order to pick up t(l 1;22) negative cases involving small insertion of material into 22ql2 it may be necessary to use probes from around the breakpoint region on chromosome 11. It is our aim to study archival material and to correlate our results with previous data on the presence or absence of t(l 1;22). Once the sequence at the breakpoint is cloned, probes immediately flanking the breakpoint could be utilised so that the presence of the translocation could be detected by finding two separate signals and a two colour doublet in affected nuclei and four separate signals in nuclei not bearing the t(ll;22). This would be achieved by labelling the sequence centromeric to the breakpoint on chromosome 11 in one colour and the sequence telomeric to the breakpoint on chromosome 22 in another colour. A similar approach is already being explored for the diagnosis of CML (Tkachuk et al., 1990) . The disadvantage of this is that if there are variations in the exact site of the breakpoint, or in the critical flanking sequences, different probes will be required to seek each variant.
In conclusion, we have described how interphase cytogenetics can be used to provide an accurate diagnostic test which should prove reliable if it is carried out by personnel familiar with the techniques involved. The relatively short time taken from receipt of the tissue sample to interpretation of results means that this technique is at least comparable to existing histological and cytochemical methods of diagnosis of these tumours. However, a positive result, when obtained, may be considerably less equivocal than the results of the existing tests. This will have obvious benefits in the clinical setting, enabling the oncologist to plan optimal therapy, and allowing frank discussion with patients and families of the natural history of the disease and its prognosis at the commencement of treatment. We believe that this approach with interphase FISH will be extended to other malignancies with translocations, deletions or amplifications in the near future, and will before long become a routine in clinical diagnosis.
Note added in proof Delattre et al. (Nature, 359, [162] [163] [164] [165] have just published the cloning of the t(ll;22) breakpoint.
